Home
>
Isotope Labeled Compounds>Isotope Labeled Metabolites>
>
(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3
For research use only. Not for therapeutic Use.
(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3 is a deuterated derivative of a complex oxazolidinone compound, featuring three deuterium atoms. This isotopically labeled compound is utilized in advanced pharmaceutical research, particularly in the study of stereospecific reactions and the development of chiral drugs. The deuterium labeling aids in precise mass spectrometric analysis, enabling researchers to track the compound’s behavior and metabolism in biological systems with high accuracy. (4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3 is an essential tool for scientists working on the synthesis and analysis of enantiomerically pure pharmaceuticals, contributing to the development of more effective and targeted therapeutics.
Catalog Number | R046767 |
CAS Number | 1329641-35-1 |
Synonyms | (4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)-2-oxiranyl]-1-oxopropyl]-4-(phenylmethyl)-2-oxazolidinone-d3; |
Molecular Formula | C21H19F2NO4 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | (4S)-4-benzyl-3-[(2S)-3,3,3-trideuterio-2-[(2R)-2-(2,4-difluorophenyl)oxiran-2-yl]propanoyl]-1,3-oxazolidin-2-one |
InChI | InChI=1S/C21H19F2NO4/c1-13(21(12-28-21)17-8-7-15(22)10-18(17)23)19(25)24-16(11-27-20(24)26)9-14-5-3-2-4-6-14/h2-8,10,13,16H,9,11-12H2,1H3/t13-,16+,21-/m1/s1/i1D3 |
InChIKey | SJRVUCOOQMMMJY-FBHDCILISA-N |
SMILES | [2H]C([2H])([2H])[C@H](C(=O)N1[C@H](COC1=O)CC2=CC=CC=C2)[C@]3(CO3)C4=C(C=C(C=C4)F)F |